TSU-68

TSU-68 · Taiho Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TSU-68, covering 2012-03-26 to 2012-03-26. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]